ArticleBMC cancer2014

CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling.

Yayun Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.